Brazil Becomes World Leader in Stem-Cell Research

    Incor BrasÀ­lia, BrazilBrazil is going to lead the greatest study of adult stem cells for treatment of heart diseases to be carried out in the world, considering the quantity of cases to be evaluated and the number of institutions involved.

    There are nearly 40 medical and research institutions evaluating 1,200 patients suffering from 4 illnesses: acute infarction of the myocardium, chronic ischemic heart disease, dilated cardiomyopathy and Chagas cardiopathy.


    The research, already being developed in the country for an effective treatment against the Chagas disease, for example, is unprecedented in the world.


    The initiative is entitled Multicentric Randomized Study for Cellular Therapy in Cardiopathies and will involve resources in the order of US$ 5 million, foreseen in the budget of the Ministry of Health.


    The objective is to substitute traditional cardiac treatments – which include surgeries, medication and even transplants -, by the therapy with stem cells.


    These cells have been studied for some years for the cure of many diseases, including some degenerative diseases such as Alzheimer’s Disease.


    Abundant in embryos and available, in smaller quantity, in more mature cellular tissues such as the umbilical cord and the bone marrow, stem cells are the matrixes that specialize to give origin to cells in specific organs such as, neurons, cardiac muscle, liver, skin, etc.


    According to the minister of Health, Humberto Costa, the government decided to invest in cellular therapy because the technique has shown promising results in the whole world and offers a less invasive treatment, with a simpler surgery and shorter internment periods.


    The patient who gets stem cells implanted in the heart can go home on the following day. Also, observed Costa, there will be a reduction in expenditure with coronary diseases in the order of US$ 173 million per year.


    Through the Single Health System (SUS) the public health system in Brazil, the government spent, in 2003, US$ 191 million with doctor’s appointments, bypass surgeries, transplants, internments and distribution of medication for hypertension and to improve heart failure.


    It is estimated that, when replacing transplants for cellular therapy, the cost of the treatment will be reduced 10 times. “It is a very significant reduction,” said the minister, although he emphasized that the main advantage is the comfort and quality of life the patient will benefit from.


    “It is a simpler procedure to be carried out, the internment period is of 24 hours, there is no risk of rejection, no collateral effect, and the improvement in operation of the cardiac muscle is evident,” he added.


    The studies will last three years and, in this period, half of the patients will receive the traditional treatment, with the best pharmacological and surgical resources available.


    The other half will receive cellular therapy. The aim is to show the technique’s efficiency, which has been shown in isolated researches in Brazil, to adopt it as a treatment if the results are positive.


    Currently, two institutions have carried out researches in the area, the Pro-Cardiac Hospital in the city of Rio de Janeiro and the Heart Institute (InCor) of the University of São Paulo (USP).


    After the efficiency of cellular therapy is confirmed, the ministry of Health will adopt the treatment in the entire chain of hospitals of the SUS.


    “This is, no doubt, the greatest cellular therapy for cardiac disorders study ever to be carried out in the world. And it will give us all the knowledge and know-how to, who knows, in a short period of time, adopt the therapy procedure in the SUS,” he foresees.


    In Brazil, 4 million people suffer of severe heart failure. If, at the end of the study, the efficiency of stem cells is proved in the recuperation of cardiac capacity, as is indicated in preliminary studies, it is estimated that 200,000 lives will be saved in three years.


    The head of the Study for Cellular Therapy in Cardiopathies will be in charge of a coordinating committee formed by the researchers involved in the study.


    The National Institute of Cardiology of Laranjeiras (INCL), in the state of Rio de Janeiro, will be the coordinating center, responsible for choosing the patients to participate in the study, monitoring them, providing technical consultancy, creating and maintaining a database, and also selecting and following the external monitors to evaluate the results.


    There will be four anchor centers, the INCL, the InCor, the Institute for Biomedical Sciences of the Federal University of Rio de Janeiro (UFRJ) in collaboration with the Pro-Cardiac Hospital and the Hospital Santa Isabel in collaboration with the Gonçalo Muniz Research Center (from the northeastern state of Bahia), of the Oswaldo Cruz Foundation (Fiocruz).


    Each one will take care, respectively, of studies with one of the target diseases of the research: dilated cardiomyopathy (INCL), chronic ischemic heart disease (InCor), acute infarction of the myocardium (UFRJ) and Chagas cardiopathy (Santa Isabel).


    About 40 collaborating centers (from the states of Paraná and Rio Grande do Sul – in southern Brazil -, São Paulo, Rio de Janeiro, Espí­rito Santo and Minas Gerais – in southeastern Brazil -, Pernambuco, Ceará and Bahia – in the Northeast – and Goiás – in the midwest -) will be linked to the ‘anchor’ to carry out the studies.


    Translated by Silvia Lindsey
    Agência Brasil

    Tags:

    • Show Comments (8)

    • Mario Venditti

      Stem cells therapy
      My 8 months nephew is hit by dilated cardiomyopathy. Before facing a transplantation surgery, do you think it possible to submit her to stem cells injection? What are the risks? what the life opportunities?
      Please answer urgently.
      Thanks.

    • Mohamed,B

      treating by stm cell
      i have diabetes type 2 , i want to treat my self by stem cell , pls let me know.

    • Mohamed,B

      treatmente by stemcell
      i have diabetes type 2 i want to treat by stem cell if possibol.pls reply.

    • Martha Mejia

      Hi my mother was diagnosed with type 1 diabetes and it has been really out of control. What are the possibilites and risks of here getting stem cell therapy?
      Please Contact me soon ceci_y_juan@yahoo.com

    • Martha Mejia

      Stem Cell Therapy
      Hi my mother was diagnosed with type 1 diabetes and it has been really out of control. What are the possibilites and risks of here getting stem cell therapy?
      Please Contact me soon

    • Jose A. Balbontin, Jr.

      RA, AND ADENOCARNOMA
      Greetings:

      Please consider me as of the most concern and interested in the stemcell research which can cure RA and adenocarcinoma cancer. My wife is suffering these illnesses and seems treatment is infinite. Please give me something to hope for in your research to cure her illnesses. Thanks a lot.

      Jose A. Balbontin, Jr., a Filipino
      email joebalbontin2004@yahoo.com

    • nita

      information
      15 year old cerebalpalcy boy want stem cell therepy anybody gide,please contect trickyshivani_94@yahoo.com

    • Guest

      Pam Salyers
      My 18 yr old son is interested in stem cell treatment for dilated cardiomyopathy. He has 10% heart function. We are interested in any information you can send us. psalyers1@cinci.rr.com
      Thank you
      Pam

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Ads

    You May Also Like

    Harvest of soy in Brazil

    Brazil Hands Out US$ 3.7 Billion for 2008/2009 Crop

    State-owned Bank of Brazil (BB) has disbursed 6.7 billion Brazilian reais (US$ 3.7 billion) ...

    UFRJ, Universidade Federal do Rio de Janeiro, Brazil

    Brazil Needs a Little Less Astuteness and a Little More Civic Engagement

    After declaring Brazil’s Independence, the Empire’s leaders decided to educate the children of the ...

    Global Call Asks for Debt Amnesty for Poor Countries, in Brazil

    More than 80 institutional representatives of civil society from around the world reunited in ...

    Ring and Rhyme

    Brazil and all other nations that speak Portuguese are once again bracing for an ...

    Brazilian real

    Brazil’s Key Interest Rate Might Drop to 9.5% Much Sooner than Expected

    Brazil Central Bank’s weekly survey of financial institutions and market analysts, known as the ...

    After 13 Years of Debates Brazil Approves Judiciary Reform

    Last night, in a second vote, the Senate approved a Judiciary Reform bill which ...

    Speedo Now Means Bike in Brazil

    Speedo, a multinational in the sports product area, is going to release a line ...

    Brazil Drafts Air Force Planes to Bring Order Back to Airports

    Brazilian President Luiz Inácio Lula da Silva has ordered that the Brazilian Air Force ...

    Brazil Gets 10 Million New Credit Cards in 3 Months. Total Now: 347 Million.

    The Brazilian market of electronic means registered an increase in 10 million credit, debit ...

    Fiocruz's equipment to produce vaccines

    Brazil Joins US to Make Royalty-Free Drugs for Orphan Diseases

    Brazil's Oswaldo Cruz Foundation (Fiocruz) and Boston-based Genzyme Corp. have joined into a research ...